Document is current
Any future updates will be listed below
-
Authors
Ding, Wern Yew https://orcid.org/0000-0003-3596-6545
Calvert, Peter
Gupta, Dhiraj
Huisman, Menno V.
Lip, Gregory Y. H.
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01468701 at ClinicalTrials.govnct01671007 at ClinicalTrials.govDocuments that mention this clinical trial
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s11239-023-02866-y
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
https://doi.org/10.1038/s41598-024-78120-z
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-022-02022-1
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
https://doi.org/10.1007/s00392-022-01996-2
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-021-01957-1
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
https://doi.org/10.1016/j.ahj.2013.12.006
nct01937377 at ClinicalTrials.govDocuments that mention this clinical trial
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s11239-023-02866-y
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
https://doi.org/10.1038/s41598-024-78120-z
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-022-02022-1
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
https://doi.org/10.1007/s00392-022-01996-2
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-021-01957-1
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
https://doi.org/10.1016/j.ahj.2013.12.006
Documents that mention this clinical trial
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s11239-023-02866-y
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
https://doi.org/10.1038/s41598-024-78120-z
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-022-02022-1
- License Information
-
More Information
Article History
Received: 26 February 2022
Accepted: 5 April 2022
First Online: 29 April 2022
